Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Salona Global Medical Device Corporation
  6. Ratings
    SGMD   CA79549X1096

SALONA GLOBAL MEDICAL DEVICE CORPORATION

(SGMD)
  Report
Delayed Bourse de Toronto  -  01:25 2022-10-05 pm EDT
0.5400 CAD   -3.57%
12:54pSalona Global Medical Device Provides Update on US$7.5 Million Sales Order
MT
07:31aSalona Global Provides Update on US$7.5M Sales Order; Expected Earnout Shares for GPO Channel Acquisition
GL
09/29Salona Global Medical Device Corp : Completion of Acquisition or Disposition of Assets, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Investment
Trading -
ESG Refinitiv -
Financials
Sales Growth
Growth rating is based on the evolution of the turnover of the company between the last year and the three coming years according to consensus estimates
Earnings Growth
This rating is based on the expected evolution of the annual net Earnings Per Share (EPS) according to the estimates of the analysts who cover the company. The objective is to identify companies with dynamic earnings growth.
-
EBITDA / Sales
This rating is based on the EBITDA margin in relation to the company's sales, based on past performance and analysts' estimates for the coming years. Unlike profitability (final net profitability), the EBITDA margin does not include taxes, interest and depreciation. The higher this ratio, the better the rating.
Profitability
Profitability rating is based on net margin of the company for the current year and the next one according to consensus estimates
Finances
Finances rating is based on the evolution of the net debt of the company (debt or cash) and its Ebitda, compared to its revenue
-
Valuation
P/E ratio
Price Earnings Ratio rating compared the company’s current share price to its per-share earnings for the current fiscal year and the next one
EV / Sales
Valuation rating is based on the ratio between enterprise value and its turnover for the current fiscal year and the next one
-
Price to Book
This rating is based on the ratio of the company's share price to its book value, based on past performance and analysts' estimates for the coming years. The lower the ratio, the better the rating.
-
Price to Free Cash Flow
This rating is based on the ratio between the company's share price and the free cash flow per share generated by its activities, based on the past and analysts' estimates for the coming years. The lower the ratio, the better the rating.
-
Yield
"Yield" rating is based on the dividend relative to its share price
-
Momentum
Turnover review 12m
Revenue revisions (one year) rating is based on the evolution of revenue revisions of the company for the current fiscal year and the next one
Turnover review 4m
Revenue revisions (four months) rating is based on the evolution of revenue revisions of the company for the current fiscal year and the next one
Turnover review 7 days
The rating is based on the evolution of the company's revenue estimates based on historical and analysts' estimates for the coming years. In the last 7 days, the more the sales estimates have been revised upwards from a relative point of view, the better the rating.
Earnings revision 12m
EPS revisions (one year) rating is based on the evolution of EPS (earnings per share) revisions of the company for the current fiscal year and the next one
Earnings revision 4m
EPS revisions (four months) rating is based on the evolution of EPS (earnings per share) revisions of the company for the current fiscal year and the next one
Consensus
Analyst Opinion
Consensus rating is based on analyst recommendations
Potential Price Target
Potential rating is based on the average target price fixed by the consensus from Thomson Reuters
Price target revision 4m
This rating is based on the evolution of the analysts' price target over the last 4 months. The objective is to identify the companies whose price target has changed the most. The more positive this variation is, the better the rating.
4m Revision of opinion
This rating is based on the evolution of the general opinion of analysts over the last 4 months. The objective is to identify the companies for which the analysts' consensus has changed the most. The more positive the change, the better the rating.
-
12m Revision of opinion
This rating is based on the evolution of the general opinion of analysts over the last 12 months. The objective is to identify the companies for which the analyst consensus has changed the most. The more positive the change, the better the rating.
Business Predictability
Analyst Coverage
This rating is based on the number of analysts present within the consensus as well as the number of numerical estimates concerning the future evolution of the company's business analysed. The more a company is followed, the better the rating.
Divergence of Estimates
Business Predictability rating is based on the dispersion of analysts' estimates on the evolution of the company business in the coming years (range estimates)
-
Divergence of analysts' opinions
This rating measures the dispersion of the different opinions of the analysts who make up the consensus. The smaller the difference of opinion, the better the rating.
-
Divergence of Target Price
This rating measures the dispersion of the different price targets of the analysts who make up the consensus. The lower the target divergence, the better the rating.
Earnings quality
Earnings quality rating is based on quality of past earnings released by the company compared to analysts' estimates
-
Technical analysis
Short Term Timing
Short Term Timing rating is defined according to the positioning of the last closed trading price, within the area between the short term support and resistance on the basis of technical analysis in daily data
-
Middle Term Timing
Mid-Term Timing rating is defined according to the positioning of the last closed trading price, within the area between the mid-term support and resistance on the basis of technical analysis in daily data
-
Long Term Timing
Long Term Timing rating is defined according to the positioning of the last closed trading price, within the area between the long term support and resistance on the basis of technical analysis in daily data
-
RSI
RSI rating is based on the ranking of the security in the panel studied according to the mathematical indicator RSI 14 period
-
Bollinger Spread
Bollinger Bands rating is based on the ranking of the security in the panel studied according to the spread of the Bollinger bands
-
Unusual Volumes
Abnormal Volumes rating is based on the ranking of the security in the panel studied according to volume of the last session compared to an average session
-
Strengths
  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
  • The company has insufficient levels of profitability.
  • For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector Other Advanced Medical Equipment & Technology
1st Jan change Capi. (M$)Investor RatingESG
SALONA GLOBAL MEDICAL DEVICE CORPORATION-12.50%23
-
THERMO FISHER SCIENTIFIC-19.08%211 539
A-
DANAHER CORPORATION-15.18%202 994
A
INTUITIVE SURGICAL, INC.-43.91%71 972
B-
BOSTON SCIENTIFIC CORPORATION-6.12%58 739
B-
EDWARDS LIFESCIENCES CORPORATION-32.71%54 047
B+
SIEMENS HEALTHINEERS AG-29.43%51 767
A-
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.-21.48%50 831
B-
AGILENT TECHNOLOGIES, INC.-20.84%38 903
A
RESMED, INC.-12.19%33 494
B+
ILLUMINA, INC.-46.10%32 256
B-
OLYMPUS CORPORATION11.27%25 991
A
WATERS CORPORATION-22.65%17 256
A-
HOLOGIC, INC.-13.07%16 614
A-
PERKINELMER, INC.-36.27%16 173
A-
PHILIPS NV-49.50%14 501
B-
More Results